US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder
In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
neuromyelitis optica spectrum disorder
US FDA grants approval of Uplizna to Viela Bio
Uplizna is the second FDA approved therapy for Neuromyelitis Optica Spectrum Disorder which offers patients additional treatment…